Results 111 to 120 of about 2,823 (147)

Efficacy and safety of low-dose rosuvastatin/ezetimibe for dyslipidemia in patients with rheumatoid arthritis or osteoarthritis. [PDF]

Medicine (Baltimore)
Bak SH, Lee KA, Kim SS, Kim SH, Hong SJ, Hong SJ, Kim HS.   +6 more
europepmc   +1 more source

Naturally Occurring PCSK9 Inhibitors: An Updated Review. [PDF]

Molecules
Huh J, Kim H.
europepmc   +1 more source

Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM? [PDF]

Diabetes Metab J
Park IR, Moon JS.
europepmc   +1 more source

Population Pharmacokinetics and Pharmacodynamics with Enterohepatic Recirculation of Co-Medication of Rosuvastatin and Ezetimibe. [PDF]

Drug Des Devel Ther
An H, Shin D.
europepmc   +1 more source

Lipid-lowering effect of combined therapy with high-intensity statins and CETP inhibitors: a Systematic Review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Xiang L, Wu H, Zhao Z, Wu T, Lv D, Wu P, Zheng Y, Huang Q, Xu T.   +8 more
europepmc   +1 more source

PCSK9 targeting therapies for familial hypercholesterolaemia: a meta-analysis of efficacy on lipid biomarkers and safety in adults and children across 23 RCTs. [PDF]

Open Heart
Ho VQT, Tran NB, Nguyen N, Arrighini GS, Downes D, Dandamudi M, Ferrara VZ, Ho THQ, Walia H, Barbagelata A, Leucker TM, Giorgi J.   +11 more
europepmc   +1 more source

The role of early ezetimibe combination with atorvastatin in patients with atherosclerotic cardiovascular disease. [PDF]

BMC Cardiovasc Disord
Kang SH, Kwon SU, Lee JY, Seo SM, Nam CW, Park GM, Hong YJ, Lee WY, Jang JE, Chae IH.   +9 more
europepmc   +1 more source

Lipid-lowering therapies for aortic stenosis: a drug-target Mendelian randomization study. [PDF]

Eur Heart J Cardiovasc Pharmacother
Ciofani JL, Han D, Rao K, Gill D, Woolf B, Rahimi K, Allahwala UK, Bhindi R.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

[Anticholesteremic agents in children].

Therapie, 2003
The treatment of hypercholesterolaemia in children is often discussed as part of the primary prevention strategy for premature coronary disease in adults. Cholesterol-lowering drugs are appropriate in children with hereditary autosomal dominant diseases such as familial hypercholesterolaemia, familial Apo B100 deficiency, or combined familial ...
openaire   +1 more source

[Anticholesteremic agents and cholelithiasis].

Nihon rinsho. Japanese journal of clinical medicine, 1978
G, Kajiyama, T, Kawamoto, A, Maruhashi, A, Miyoshi   +3 more
openaire   +1 more source